PenderFund Capital Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

PenderFund Capital Management’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-160	Closed	-$45K	–	140
2022 Q4	$45K	Hold	160	–	–	0.01%	129
2022 Q3	$61K	Hold	160	–	–	0.02%	154
2022 Q2	$39K	Hold	160	–	–	0.01%	158
2022 Q1	$41K	Buy	+160	New	+$26.4K	0.01%	152

Other funds holding SWAV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

PenderFund Capital Management's SWAV Position: Q1 2023 in Review

PenderFund Capital Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q1 2023, closing a stake of 160 shares — an estimated $45K sold.

PenderFund Capital Management first reported a position in SWAV in Q1 2022 and held it in 4 quarters. The position peaked at $61K in Q3 2022. 381 funds tracked by Wall St. Rank hold SWAV as of Q1 2023.

PenderFund Capital Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
PenderFund Capital Management sold 160 Shockwave Medical, Inc. Common Stock shares in Q1 2023, an estimated $45K.
PenderFund Capital Management first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
PenderFund Capital Management's Shockwave Medical, Inc. Common Stock position peaked at $61K in Q3 2022.
381 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q1 2023.

Based on PenderFund Capital Management's 13F filing for Q1 2023, filed 15 May 2023.